The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease
NCT ID: NCT01055730
Last Updated: 2013-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
54 participants
OBSERVATIONAL
2010-02-28
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pulmonary rehabilitation
Pulmonary rehabilitation
Structured education and supervised exercise program, lasting between 6 and 9 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pulmonary rehabilitation
Structured education and supervised exercise program, lasting between 6 and 9 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Inability to read and write English
* Any other medical condition that significantly limits the subject's ability to perform the functional measures
* Emphysema / Chronic bronchitis (FEV1 / FVC ratio \< 60%)
* Previous pulmonary rehabilitation
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, San Francisco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Harold R Collard, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Christopher J Ryerson, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Chris Garvey, FNP
Role: PRINCIPAL_INVESTIGATOR
Seton Pulmonary & Cardiac Rehabilitation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
John Muir Health
Concord, California, United States
Seton Pulmonary & Cardiac Rehabilitation
Daly City, California, United States
Yale University School of Medicine
New Haven, Connecticut, United States
Duke University Medical Center
Durham, North Carolina, United States
Inova Fairfax Hospital
Falls Church, Virginia, United States
University of British Columbia
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ryerson CJ, Cayou C, Topp F, Hilling L, Camp PG, Wilcox PG, Khalil N, Collard HR, Garvey C. Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study. Respir Med. 2014 Jan;108(1):203-10. doi: 10.1016/j.rmed.2013.11.016. Epub 2013 Dec 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PR-ILD
Identifier Type: -
Identifier Source: org_study_id